Resveratrol as a multitarget modulator in diabetic retinopathy: a systematic review of in vitro and in vivo studies

Key Points

• Resveratrol demonstrates protective effects against diabetic retinopathy through various mechanisms.
• Key evidence includes findings from both in vitro and in vivo studies, revealing increased neuroprotection in measurable aspects.
• This systematic review aggregates results from multiple studies assessing resveratrol's multitarget modulation in diabetic retinopathy.
• Findings highlight resveratrol's potential as a therapeutic agent, but further clinical research is needed.